Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy.
Sung Han KimJung Kwon KimEun Young ParkJungnam JooKang Hyun LeeHo Kyung SeoJae Young JoungSung Han KimPublished in: PloS one (2019)
Poor Heng risk, sex, and liver metastasis were associated with survival outcomes after first-line systemic therapy in patients with non-nephrectomized synchronous mRCC.